2m 2m 2m 2m 2m 2m 2m
Akebia Therapeut (AKBA)
NASDAQ
$0.57+$0.007 (+1.21%)
Price as of Oct 22, 2026 7:59 PM EDT- $162.2MMarket Cap
- -80.42%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Akebia Therapeut (AKBA)
$0.57+$0.007 (+1.21%)
AKBA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.56 | ||
Change | -$0.03 (-5.31%) | ||
Open | $0.58 | ||
High | $0.60 | ||
Low | $0.54 | ||
Previous Close | $0.59 | ||
Volume | 13,102,683 | ||
30-Day Average Volume | 7,743,199 | ||
1-Week Change | -16.62% | ||
1-Month Change | -37.63% | ||
1-Year Change | -80.42% | ||
3-Year Change | -29.47% | ||
5-Year Change | -79.82% | ||
Fundamentals | |||
Shares Outstanding | 277.1M | ||
Total Assets | $349.7M | ||
Market Cap | $162.2M | ||
Enterprise Value | $56.2M | ||
Period: QTR TTM FY | |||
Revenue | $46.8M | ||
Net Income | -$8.9M | ||
Free Cash Flow | $2.4M | ||
EBIT | -$5.8M | ||
EBITDA | -$5.2M | ||
Net Working Capital | $68.7M | ||
EPS | -$0.03 | ||
Enterprise Value/EBITDA | -11 | ||
Enterprise Value/Revenue | 1 | ||
P/B | 6 | ||
P/E | -20 | ||
PEG | N/A | ||
Price/Free Cash Flow | 66 | ||
Price/Operating Cash Flow | 46 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue